Logo

CardioDx

Acarix Positions Acoustic Test for Ruling out CAD as Alternative to Invasive Methods
Premium

Since it launched CADscor, which could compete against molecular tests, in the second quarter, Acarix has announced clients in Germany, Denmark, and Sweden.

Data Presented on Prevencio Coronary Artery Disease Panel as Firm Targets FDA Submission
Premium

The developer has presented clinical results that provide a base for completing development of a multi-protein test kit and conducting a clinical trial in advance of FDA submission.